A-Z Index
Browse this A-Z index for HRPO Guidance. The links will connect you directly to the guidelines, forms, checklists, training, and resources you need. For any topic that might be missing from this index, please email askirb@pitt.edu.
-
A
-
B
-
C
- Case Reports
- Certificate of Confidentiality Guidance
- Certificate of Confidentiality NIH
- Children in Research
- Child Clearances
- Children's Online Privacy Protection Act (COPPA)
- CITI Training
- ClinicalTrials.gov
- Cohort Discovery
- Common Rule [45 CFR 46]
- Common Rule 2018
- IRB Community Member Frequently Asked Questions
- Continuing Review - OHRP Guidance
- Continuing Review - Research Milestones
- Coordinating Center Applications and Responsibilities
- Coordinating Center Application Supplement [Word]
- COVID-19 Human Subject Research FAQ
- COVID-19 Information Sheet for Participants
- COVID-19: Research Participant Screening Questions
- Crowdsourcing Platforms
Consent Guidance
- Building Your Consent Document
- Child Research Signature Lines
- Consent Forms in Medical Records
- Consent Form Posting for Federally Funded Clinical Trials
- Decisional Impairment and Proxy Signature Lines
- Family Members Information
- Informed Consent for Secondary Research with Data and Biospecimens (NIH Sample Language)
- Key Information
- Low Literacy and Disabled Participants
- Not Reasonably Available
- Obtaining Informed Consent
- Reconsent
- Short Form Consent Documents
- Top Ten Tips to Improve Consent Form Readablity
- UPMC Cost Language
-
D
- Data and Safety Monitoring Plan
- Data and Safety Monitoring Board/Committee
- Data Management-University Guidelines
- Data Risk Classification and Compliance
- Data Security-Pitt Information Technology Research Resources
- Data Security for Researchers
- Data Security Management Tips
- UPMC Data Use Agreement for Limited Data Set [Word]
- Data Use Agreement (DUA)
- Decedent Research
- Decisional Impairment Checklist [Word]
- Declaration of Helsinki
- Department of Defense (DOD) Checklist [pdf]
- Device (PittPRO)
- Drug Evaluation and Research - FDA Guidance
- Drug (PittPRO)
-
E
Emergency Use (EU) and Single Patient Expanded Access
-
F
- Faculty Mentor Responsibilities
- Faculty Mentor Quick Reference
- FDA: Medical Devices
- FDA: Medical Apps
- FDA: Drugs
- FDA: Good Clinical Practice
- FDA: Guidance for IRBs, Clinical Investigators, and Sponsors
- FDA: Decisions for Investigational Device Exemption Clinical Investigations(issued 8.19.2014)
- FDA: MedWatch
- FDA Online Label Repository
- Family Educational Rights and Privacy Act (FERPA)
- Federal Wide Assurance -DHHS
- Federal Wide Assurance (FWA) and Engaged in Research
- Finder's Fees and Recruitment Incentives
-
G
-
H
- HIPAA
- HIPAA Checklist: Example Language
- HIPAA Privacy Rule - Databases and Research Repositories - NIH Guidance
- HIPAA Privacy Rule Information for IRBs - NIH Guidance
- HIPAA Privacy Rule Information for Researchers - NIH Guidance
- HIPAA Safe Harbor vs Limited Data Set
- Honest Broker
- Honest Broker Application [Word]
- Honest Broker Assurance Form
-
I
-
J
-
K
-
L
-
M
-
N
-
O
-
P
PittPRO Information
-
Q
-
R
- Radiation Guidance
- Research Restart (Archived)
- Returning to UPMC Facilities: Guidelines for Researchers
Reliance Guidance
- Individual Investigator Agreement (IIA)
- IRB Fee Sheet
- Overview of Reliance Request System Content [pdf]
- Pitt Cede IRB Review [pdf]
- Pitt IRB of Record [pdf]
- Reliance Request System
- sIRB Overview
Reportable New Information
-
S
-
T
-
U
-
V
-
W
-
X
-
Y
-
Z